Cigna (CI) stock
Health Care · Health Care Services
Cigna (CI) is a Health Care Services company in the Health Care sector, headquartered in Bloomfield, Connecticut. As of October 23, 2026, CI closed at $306.95, a market capitalization of $81.11 billion, the 156th largest company in the S&P 500. The stock trades at 12.7x trailing earnings and 9.2x forward earnings.
- 1-year total return: +2.9% (dividends reinvested)
- 5-year return: +9.3% a year
- 52-week range: $239.51 – $316.27
- Dividend yield: 2.03%, 5 straight years of increases
- FI Handbook report card: A across 5 metrics
- 22nd largest of 60 Health Care stocks in the S&P 500
CI price chart
1Y price change: +0.6% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| CI | +14.4% | +13.4% | +2.9% | +2.6% | +9.3% | +10.6% | +11.8% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 1982.
CI key statistics
- Market cap
- $81.1B
- #156 in S&P 500
- P/E (TTM)
- 12.7x
- Forward P/E
- 9.2x
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Free cash flow
- $9.1B
- Gross margin
- —
- Operating margin
- —
- Return on equity
- —
- Dividend yield
- 2.03%
- 52-week range
- $239.51 – $316.27
- Beta
- —
- Price / sales
- —
- EV / EBITDA
- —
- Debt / equity
- —
- Employees
- —
CI report card
ATen fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth——
- Gross margin——
- Operating margin——
- FCF margin——
- Return on equity——
- Net debt / EBITDA0.0xA
- Forward P/E9.2xA
- PEG ratio0.8xA
- Shareholder yield6.5%A
- Share count change / yr-6.1%A
Cigna financials
Revenue went from $39.8B in fiscal 2016 to $274.9B in fiscal 2025, growing 23.9% a year.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.8B | $41.8B | $48.6B | $153.6B | $160.4B | $174.1B | $180.5B | $195.3B | $247.1B | $274.9B |
| Gross profit | $37.4B | $39.4B | $43.9B | $55.9B | $56.9B | $56.5B | $55.7B | $61.5B | $64.6B | $59.9B |
| Operating income | $3.1B | $3.9B | $4.2B | $8.1B | $8.2B | $7.9B | $8.4B | $8.5B | $9.4B | $9.2B |
| Net income | $1.8B | $2.2B | $2.6B | $5.1B | $8.5B | $5.4B | $6.8B | $5.2B | $3.4B | $6.0B |
| EPS (diluted) | $7.19 | $8.77 | $10.54 | $13.44 | $22.96 | $15.75 | $21.41 | $17.39 | $12.12 | $22.18 |
| Free cash flow | $3.6B | $3.6B | $3.2B | $8.4B | — | — | — | — | — | — |
| Buybacks | $139.0M | $2.7B | $342.0M | $2.0B | $4.0B | $7.7B | $7.6B | $2.3B | $7.0B | $3.6B |
| Dividends paid | — | — | — | $15.0M | $15.0M | $1.3B | $1.4B | $1.4B | $1.6B | $1.6B |
| Diluted shares | 259.6M | 255.1M | 250.2M | 379.8M | 368.4M | 341.0M | 313.1M | 296.9M | 283.2M | 268.6M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into CI?
A reverse DCF asks what growth the current price requires. With an enterprise value of $81.1B and $9.1B of trailing free cash flow, Cigna needs to grow free cash flow about -9.0% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew 33.3% a year over the last five years.
P/E ratio history
Current 13.8x vs. median 17.4x (10th–90th percentile 11.4x–25.1x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
CI dividend
- Dividend yield
- 2.03%
- Annual dividend
- $6.24
- Years of increases
- 5
- 5-yr dividend growth
- 172.8%
- per year
- Payments per year
- 4
Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.
CI analyst price targets
24 analysts' average 12-month target is $342.29 (+12% vs. $306.95). Targets range from $288.00 to $400.00. 71% rate it a buy.
CI earnings
Next report: November 5, 2026. Cigna has beaten EPS estimates 6 quarters in a row. Last quarter's revenue was $71.4B (+7% year over year).
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Jul 30, 2026 | $7.60 | $7.78 | +2.4% |
| Apr 30, 2026 | $7.61 | $7.79 | +2.4% |
| Feb 5, 2026 | $7.88 | $8.08 | +2.5% |
| Oct 30, 2025 | $7.64 | $7.83 | +2.5% |
| Jul 31, 2025 | $7.15 | $7.20 | +0.7% |
| May 2, 2025 | $6.35 | $6.74 | +6.2% |
| Jan 30, 2025 | $7.82 | $6.64 | -15.1% |
| Oct 31, 2024 | $7.25 | $7.51 | +3.5% |
Stocks like CI
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 CVS CVS Health | -1.07% | +19% | $119.5B | 24.6x | Compare |
 DGX Quest Diagnostics | -0.57% | +34% | $26.7B | 24.1x | Compare |
 LH Labcorp | -0.30% | +17% | $26.7B | 27.2x | Compare |
 DVA DaVita | -1.32% | +43% | $11.7B | 15.5x | Compare |
 LLY Eli Lilly and | -2.54% | +56% | $1.1T | 42.7x | Compare |
 JNJ Johnson & Johnson | -1.42% | +40% | $635.1B | 40.0x | Compare |
 ABBV AbbVie | +0.16% | +29% | $504.8B | 80.7x | Compare |
 UNH UnitedHealth | -1.62% | +19% | $375.3B | 26.9x | Compare |
CI news
- Has Buying Cigna Stock At A High Paid Off? · Oct 23, 2026
- Is Cigna (CI) Quietly Reframing Its Moat Around Data-Driven Care With Health Sense? · Oct 15, 2026
- The Cigna Group’s Forward P/E Signals Value. Earnings Risks Remain · Oct 14, 2026
- What You Need to Know Ahead of The Cigna Group’s Earnings Release · Oct 13, 2026
- What Will Decide UnitedHealth Group Stock Over The Next Six Months? · Oct 23, 2026
CI stock FAQ
What is CI's market cap?
Cigna's market capitalization is $81.11 billion as of October 23, 2026, ranking 156th in the S&P 500.
What is CI's P/E ratio?
CI trades at a trailing price-to-earnings ratio of 12.7x and a forward P/E of 9.2x. Its median P/E over the period we track is 17.4x.
Does CI pay a dividend?
Yes. Cigna pays $6.24 per share a year, a 2.03% yield. It has raised its dividend 5 years in a row. Dividends grew 172.8% a year over the last five years.
How much has CI stock returned?
Including reinvested dividends, CI returned +2.9% over one year, +9.3% a year over five years, +10.6% a year over ten years through October 23, 2026.
Is CI stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies Cigna must grow free cash flow about -9% a year for the next decade. Its free cash flow grew 33% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the CI price target?
24 analysts cover CI with an average 12-month price target of $342.29, +12% from the current price. 71% of them rate it a buy.
When does CI report earnings?
Cigna is expected to report earnings on November 5, 2026. It has beaten EPS estimates 6 quarters in a row.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology